Kamisha L. Johnson-Davis, Ph.D. - Publications

Affiliations: 
2004 University of Utah, Salt Lake City, UT 
Area:
Pharmacology

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Rule GS, Rockwood AL, Johnson-Davis KL. Quantitation of Teriflunomide in Human Serum/Plasma Across a 40,000-Fold Concentration Range by LC/MS/MS. Methods in Molecular Biology (Clifton, N.J.). 1383: 195-203. PMID 26660188 DOI: 10.1007/978-1-4939-3252-8_21  0.8
2016 Slawson MH, Johnson-Davis KL. Quantitation of Ethyl Glucuronide and Ethyl Sulfate in Urine Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 167-75. PMID 26660185 DOI: 10.1007/978-1-4939-3252-8_18  0.8
2016 Slawson MH, Johnson-Davis KL. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 105-14. PMID 26660179 DOI: 10.1007/978-1-4939-3252-8_12  0.8
2016 Slawson MH, Johnson-Davis KL. Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 49-57. PMID 26660173 DOI: 10.1007/978-1-4939-3252-8_6  0.8
2016 Slawson MH, Johnson-Davis KL. Quantitation of Flecainide, Mexiletine, Propafenone, and Amiodarone in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 1383: 11-9. PMID 26660169 DOI: 10.1007/978-1-4939-3252-8_2  0.8
2016 Dasgupta A, Khalil SA, Johnson-Davis KL. Analytical performance evaluation of a new Cobas tacrolimus assay on Cobas e411 analyzer: Comparison of values obtained by the CMIA tacrolimus assay and a liquid chromatography combined with tandem mass spectrometric method Annals of Clinical and Laboratory Science. 46: 204-208.  0.8
2015 Johnson-Davis KL, Sadler AJ, Genzen JR. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory. Journal of Analytical Toxicology. PMID 26668238 DOI: 10.1093/jat/bkv133  0.8
2015 Marin SJ, Doyle K, Chang A, Concheiro-Guisan M, Huestis MA, Johnson-Davis KL. One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. Journal of Analytical Toxicology. PMID 26342055 DOI: 10.1093/jat/bkv101  0.8
2015 Johnson-Davis KL, Slawson MH. Ethyl Glucuronide Positivity Rate in a Pain Management Population. Journal of Analytical Toxicology. 39: 686-90. PMID 26324207 DOI: 10.1093/jat/bkv096  0.8
2015 Schniedewind B, Niederlechner S, Galinkin JL, Johnson-Davis KL, Christians U, Meyer EJ. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study. Therapeutic Drug Monitoring. 37: 296-303. PMID 25970506 DOI: 10.1097/FTD.0000000000000191  0.8
2015 Johnson-Davis KL, Juenke JM, Thomas RL, Bradshaw T. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients. Annals of Clinical and Laboratory Science. 45: 27-31. PMID 25696007  0.8
2015 McMillin GA, Marin SJ, Johnson-Davis KL, Lawlor BG, Strathmann FG. A hybrid approach to urine drug testing using high-resolution mass spectrometry and select immunoassays. American Journal of Clinical Pathology. 143: 234-40. PMID 25596249 DOI: 10.1309/AJCPMJKBC6VJA1SP  0.8
2015 Rule GS, Rockwood AL, Johnson-Davis KL. LC-MS/MS Method for Determination of Teriflunomide, Over a 40,000-Fold Dynamic Range Using Overlapping Calibrators. Therapeutic Drug Monitoring. 37: 472-8. PMID 25525756 DOI: 10.1097/FTD.0000000000000166  0.8
2015 Marin SJ, Sawyer JC, He X, Johnson-Davis KL. Comparison of drug detection by three quadrupole time-of-flight mass spectrometry platforms. Journal of Analytical Toxicology. 39: 89-95. PMID 25505058 DOI: 10.1093/jat/bku134  0.8
2014 Lin CN, Juenke JM, Johnson-Davis KL. Method validation of a tricyclic antidepressant drug panel in urine by UPLC-MS/MS. Annals of Clinical and Laboratory Science. 44: 431-6. PMID 25361928  0.8
2014 Petrides AK, Moskowitz J, Johnson-Davis KL, Jannetto PJ, Langman LJ, Clarke W, Marzinke MA. The development and validation of a turbulent flow-liquid chromatography-tandem mass spectrometric method for the simultaneous quantification of citalopram, sertraline, bupropion and hydroxybupropion in serum. Clinical Biochemistry. 47: 73-9. PMID 25087976 DOI: 10.1016/j.clinbiochem.2014.07.018  0.8
2013 McMillin GA, Slawson MH, Marin SJ, Johnson-Davis KL. Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management. Journal of Pain & Palliative Care Pharmacotherapy. 27: 322-39. PMID 24147959 DOI: 10.3109/15360288.2013.847889  0.8
2013 Juenke JM, Brown PI, Urry FM, Johnson-Davis KL, McMillin GA. Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma. Clinica Chimica Acta; International Journal of Clinical Chemistry. 423: 32-4. PMID 23618971 DOI: 10.1016/j.cca.2013.04.014  0.8
2013 McMillin GA, Johnson-Davis KL. Issues of Interferences in Therapeutic Drug Monitoring Accurate Results in the Clinical Laboratory: a Guide to Error Detection and Correction. 195-211. DOI: 10.1016/B978-0-12-415783-5.00013-X  0.8
2012 Johnson-Davis KL, Juenke JM, Davis R, McMillin GA. Quantification of tricyclic antidepressants using UPLC-MS/MS. Methods in Molecular Biology (Clifton, N.J.). 902: 175-84. PMID 22767118 DOI: 10.1007/978-1-61779-934-1_16  0.8
2012 Johnson-Davis KL, Thompson CD, Clark CJ, McMillin GA, Lehman CM. Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department. Journal of Analytical Toxicology. 36: 345-8. PMID 22582270 DOI: 10.1093/jat/bks028  0.8
2012 Juenke JM, McGraw JP, McMillin GA, Johnson-Davis KL. Performance characteristics and patient comparison of the ARK Diagnostics levetiracetam immunoassay with an ultra-high performance liquid chromatography with tandem mass spectrometry detection method. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 529-31. PMID 22137980 DOI: 10.1016/j.cca.2011.11.018  0.8
2011 Johnson-Davis KL, Fernelius C, Eliason NB, Wilson A, Beddhu S, Roberts WL. Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study. Annals of Clinical and Laboratory Science. 41: 331-9. PMID 22166502  0.8
2011 Rockwood AL, Johnson-Davis KL. Mass spectrometry for clinical toxicology: therapeutic drug management and trace element analysis. Clinics in Laboratory Medicine. 31: 407-28. PMID 21907106 DOI: 10.1016/j.cll.2011.07.003  0.8
2011 Johnson-Davis KL, De S, Jimenez E, McMillin GA, De BK. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method. Therapeutic Drug Monitoring. 33: 453-9. PMID 21743377 DOI: 10.1097/FTD.0b013e3182263981  0.8
2011 Juenke JM, Miller KA, Ford MA, McMillin GA, Johnson-Davis KL. A comparison of two FDA approved lamotrigine immunoassays with ultra-high performance liquid chromatography tandem mass spectrometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. 412: 1879-82. PMID 21693111 DOI: 10.1016/j.cca.2011.06.009  0.8
2011 Juenke JM, Wienhoff KA, Anderson BL, McMillin GA, Johnson-Davis KL. Performance characteristics of the ARK diagnostics gabapentin immunoassay. Therapeutic Drug Monitoring. 33: 398-401. PMID 21654348 DOI: 10.1097/FTD.0b013e318220bb65  0.8
2011 Juenke JM, Miller KA, McMillin GA, Johnson-Davis KL. An automated method for supporting busulfan therapeutic drug monitoring. Therapeutic Drug Monitoring. 33: 315-20. PMID 21544019 DOI: 10.1097/FTD.0b013e318214cd75  0.8
2011 Juenke JM, Brown PI, Johnson-Davis KL, McMillin GA. Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection. Therapeutic Drug Monitoring. 33: 209-13. PMID 21297550 DOI: 10.1097/FTD.0b013e31820b1fce  0.8
2011 McMillin GA, Johnson-Davis KL. In reply Clinical Chemistry. 57: 644-645. DOI: 10.1373/clinchem.2010.160598  0.8
2010 Johnson-Davis KL, Thompson CD, Clark CJ, McMillin GA, Lehman CM. High amphetamine/methamphetamine concentrations in urine can cause error codes on the Ortho Vitros® Fusion 5,1 FS automated chemistry analyzer. Journal of Analytical Toxicology. 34: 607-8. PMID 21073817  0.8
2010 Johnson-Davis KL, McMillin GA, Juenke JM, Ford CD, Petersen FB. Which dose of busulfan is best? Clinical Chemistry. 56: 1061-4. PMID 20585045 DOI: 10.1373/clinchem.2009.134940  0.8
2009 Johnson-Davis KL, Moore SJ, Owen WE, Cutler JM, Frank EL. A rapid HPLC method used to establish pediatric reference intervals for vitamins A and E. Clinica Chimica Acta; International Journal of Clinical Chemistry. 405: 35-8. PMID 19361489 DOI: 10.1016/j.cca.2009.03.058  0.8
2007 Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, Wilkins DG. Persistence of tolerance to methamphetamine-induced monoamine deficits. European Journal of Pharmacology. 559: 46-54. PMID 17239369 DOI: 10.1016/j.ejphar.2006.11.045  0.8
2005 Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. Bupropion increases striatal vesicular monoamine transport. Neuropharmacology. 49: 820-30. PMID 16005476 DOI: 10.1016/j.neuropharm.2005.05.004  0.8
2005 Truong JG, Wilkins DG, Baudys J, Crouch DJ, Johnson-Davis KL, Gibb JW, Hanson GR, Fleckenstein AE. Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity. The Journal of Pharmacology and Experimental Therapeutics. 314: 1087-92. PMID 15901804 DOI: 10.1124/jpet.105.085951  0.8
2004 Johnson-Davis KL, Truong JG, Fleckenstein AE, Wilkins DG. Alterations in vesicular dopamine uptake contribute to tolerance to the neurotoxic effects of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 309: 578-86. PMID 14747615 DOI: 10.1124/jpet.103.062695  0.8
2003 Johnson-Davis KL, Fleckenstein AE, Wilkins DG. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. European Journal of Pharmacology. 482: 151-4. PMID 14660016 DOI: 10.1016/j.ejphar.2003.09.063  0.8
2003 Johnson-Davis KL, Hanson GR, Keefe KA. Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats. Neurotoxicity Research. 5: 273-81. PMID 12835119 DOI: 10.1007/BF03033385  0.8
2002 Johnson-Davis KL, Hanson GR, Keefe KA. Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression. Journal of Neurochemistry. 82: 1472-9. PMID 12354295 DOI: 10.1046/j.1471-4159.2002.01095.x  0.8
Show low-probability matches.